Participant demographic and clinical characteristics. Values mean (SD) unless otherwise specified.
| Characteristic | Gout, n = 24 | Control, n = 24 | p |
|---|---|---|---|
| Age, yrs | 61.9 (12.0) | 61.7 (12.3) | 0.95 |
| Male sex, n (%) | 22 (92) | 22 (92) | 0.99 |
| Ethnicity, n (%) | |||
| European | 14 (58) | 23 (96) | < 0.01 |
| Māori | 1 (4) | 1 (4) | |
| Pasifika | 6 (25) | 0 (0) | |
| Asian | 3 (13) | 0 (0) | |
| BMI, kg/m2 | 31.1 (4.1) | 26.3 (5.1) | 0.01 |
| Disease duration, yrs | 17.4 (11.9) | — | — |
| Age at first episode, yrs | 44.3 (18.8) | — | — |
| Flares in preceding 3 mos | 1.2 (1.5) | — | — |
| Hypertension, n (%) | 17 (71) | 7 (29) | < 0.01 |
| Cardiovascular disease, n (%) | 8 (33) | 2 (8) | 0.03 |
| Type 2 diabetes, n (%) | 7 (29) | 2 (8) | 0.07 |
| Diuretic use, n (%) | 9 (38) | 9 (38) | 1.00 |
| Urate-lowering therapy, n (%) | 22 (92) | — | — |
| Foot tophus count | 2.2 (3.3) | — | — |
| Total tophus count | 7.2 (7.4) | — | — |
| Serum urate, mmol/l | 0.37 (0.11) | — | — |
BMI: body mass index.